Interactions of the dye Evans Blue and GYKI 52466, a 2,3-benzodiazepine, with (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured rat cortical neurons: Electrophysiological evidence for at least two different binding sites for non-competitive antagonists

Neuroscience Letters

Volumn 216, Issue 1, 1996, Pages 29-32

  Weiser, Thomas ^a   Herrmann, Almut ^b   Wienrich, Marion ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

(S) amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid (AMPA); Evans Blue; Glutamate receptor; GYKI 52466; Kainate; Non competitive antagonism

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR; EVANS BLUE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL CULTURE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EMBRYO; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030595301     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12995-5     Document Type: Article

References (12)

1. [1] Desai, M.A., Burnett, J.P., Ornstein, P.L. and Schoepp, D.D., Cyclothiazide acts at a site on the (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists, J. Pharmacol. Exp. Ther., 272 (1994) 38-43.
2. [2] Dichter, M., Rat cortical neurons in culture: culture methods, cell morphology, electrophysiology and synapse formation. Brain Res., 149 (1987) 279-293.
3. [3] Donevan, S.D. and Rogawski, M.A., GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/ kainate receptor responses. Neuron, 10 (1993) 51-59.
4. [4] Johansen, T.H., Chaudhary, A. and Verdoorn, T.A., Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Mol. Pharmacol., 48 (1995) 946-955.
5. [5] Keller, B.U., Blaschke, M., Rivosecchi, R., Hollmann, M., Heinemann, S.F. and Konnerth, A., Identification of a subunit-specific antagonist of (S)-α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate/kainate receptor channels, Proc. Natl. Acad. Sci. USA. 90 (1993) 605-609.
6. [6] Kessler, M., Arai, A., Quan, A. and Lynch, G., Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466, Mol. Pharmacol., 49 (1996) 123-131.
7. [7] LePeillet, E., Arvin, B., Moncada, C. and Meldrum, B.S., The non-NMDA antagonists. NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischemia in the rat, Brain Res., 571 (1992) 115-120.
8. [8] Partin, K.M. and Mayer, M.L., Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655, Mol. Pharmacol., 49 (1996) 142-145.
9. [9] Rammes, G., Parsons, C., Müller, W. and Swandulla, D., Modulation of fast excitatory synaptic transmission by cyclothiazide and GYKI 52466 in the rat hippocampus, Neurosci. Lett., 175 (1994) 21-24.
10. [10] Rammes, G., Swandulla, D., Collingridge, G.L., Hartmann, S. and Parsons, C.G., Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurons and area CA1 in hippocampal slices, Br. J. Pharmacol., 117 (1996) 1209-1221.
11. [11] Randle, J.C.R., Guet, T., Bobichon, C., Moreau, C., Curutchet, P., Lambolez, B., Prado de Carvalho, L., Cordi, A. and Lepagnol, J.M., Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials, Mol. Pharmacol., 41 (1992) 337-345.
12. [12] Yamada, K.A. and Turetsky, D.M., Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists, Br. J. Pharmacol., 117 (1996) 1663-1672.